{"name": "Affinium Pharmaceuticals",
 "permalink": "affinium-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/affinium-pharmaceuticals",
 "homepage_url": "http://www.afnm.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "oroberts@afnm.com",
 "phone_number": "416-645-6614",
 "description": "",
 "created_at": "Tue Aug 30 03:25:25 UTC 2011",
 "updated_at": "Thu Mar 28 04:27:44 UTC 2013",
 "overview": "\u003Cp\u003EAffinium Pharmaceuticals is a specialty pharmaceutical company focused on the development of novel anti-infective medicines. The Affinium FASII antibacterial programs constitute a new antibiotic franchise with the potential for multiple products targeting the FASII pathway. These programs include a broad base of long-term intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors for a new class of antibiotics with a unique mechanism of action, targeting an underexploited pathway.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       55],
      "assets/images/resized/0015/1756/151756v1-max-150x150.png"],
     [[250,
       93],
      "assets/images/resized/0015/1756/151756v1-max-250x250.png"],
     [[260,
       97],
      "assets/images/resized/0015/1756/151756v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chief Executive Officer",
    "person":
     {"first_name": "Ed",
      "last_name": "Mascioli",
      "permalink": "ed-mascioli",
      "image": null}},
   {"is_past": false,
    "title": "Chief Medical Officer",
    "person":
     {"first_name": "Barry",
      "last_name": "Hafkin",
      "permalink": "barry-hafkin",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Owen",
      "last_name": "Roberts",
      "permalink": "owen-roberts",
      "image": null}},
   {"is_past": true,
    "title": "Chairman and CEO",
    "person":
     {"first_name": "John",
      "last_name": "Mendlein",
      "permalink": "john-mendlein",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$15M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.afnm.com/news/affinium-news-082911.htm",
    "source_description": "Affinium Pharmaceuticals Announces the Closing of $15 Million Financing",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 8,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Genesis Capital",
         "permalink": "genesis-capital",
         "image":
          {"available_sizes":
            [[[150,
               29],
              "assets/images/resized/0008/3192/83192v1-max-150x150.jpg"],
             [[250,
               49],
              "assets/images/resized/0008/3192/83192v1-max-250x250.jpg"],
             [[415,
               82],
              "assets/images/resized/0008/3192/83192v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Forward Ventures",
         "permalink": "forward-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9546/49546v1-max-150x150.png"],
             [[250,
               33],
              "assets/images/resized/0004/9546/49546v1-max-250x250.png"],
             [[384,
               52],
              "assets/images/resized/0004/9546/49546v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "7000 North Mopac Expwy.",
    "address2": "2nd Floor",
    "zip_code": "78731",
    "city": "Austin",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}